New drug protocol tested for rare blood disorder
NCT ID NCT02203396
Summary
This study tested an optimized combination of three existing drugs (rabbit ATG, cyclosporine, and levamisole) as a first treatment for severe aplastic anemia. The treatment aimed to suppress the immune system's attack on the bone marrow and help blood counts recover. Researchers enrolled 40 newly diagnosed patients in China to see if this 9-day protocol was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 300020, China
Conditions
Explore the condition pages connected to this study.